Heart, bone, and hydration strategies remain central to long-term health
Recent M&A Moves in the GLP-1 Landscape The following transactions illustrate the growing M&A momentum in the GLP-1 space: (2023): Roches Acquisition of Carmot Therapeutics Roche paid US$2.7 billion upfront for Carmot, a clinical-stage biotech with a promising portfolio of incretin-based therapies, including dual GLP-1/GIP agonists
Support Collagen Production Collagen is the structural protein that keeps skin firm and smooth
Caspase-1 also processes and promotes the maturation and release of IL-1 and IL-18, enhancing the local inflammatory response (Kovacs and Miao, 2017)
So, when the FDA officially pulled the plug on compounded GLP-1s recently, it left many of us wondering: Do I need to stop my treatment
Deciphering Tumor Ecosystems in Space and Time: Single-Cell Cancer Biology Gordon Research Conference